Risk stratification and timing of revascularization: which patients benefit from early versus later

Ian J Sarembock1, Dean J Kereiakes

  • 1The Christ Hospital Heart and Vascular Center and The Lindner Research Center at The Christ Hospital, 2123 Auburn Avenue, Cincinnati, OH 45219, USA. sarembock@ohioheart.org

Insights

Risk stratification for acute coronary syndromes without ST elevation uses clinical, ECG, and biological markers. Guidelines recommend early invasive treatment for high-risk NSTEACS patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Emergency Medicine

Background:

  • Risk stratification is crucial for acute coronary syndromes (ACS), especially non-ST-elevation ACS (NSTEACS).
  • Accurate risk assessment guides treatment decisions and improves patient outcomes.
  • Current stratification relies on clinical, electrocardiogram (ECG), and biological markers.

Purpose of the Study:

  • To review risk stratification markers and therapeutic strategies for NSTEACS.
  • To highlight the importance of early invasive treatment for high-risk NSTEACS patients.

Main Methods:

  • Review of clinical, ECG, and biological markers for NSTEACS risk stratification.
  • Analysis of established risk scores like TIMI and GRACE.
  • Evaluation of therapeutic strategies: routine invasive vs. conservative/selective invasive.

Main Results:

  • Key predictors of adverse outcomes in NSTEACS include recent angina, ST-segment deviation on ECG, elevated troponin, myocardial dysfunction markers (BNP, NT-proBNP), and inflammation markers (hs-CRP).
  • TIMI and GRACE scores are widely used for risk prediction.
  • An early invasive strategy (8-24 hours) is recommended for intermediate to high-risk NSTEACS patients.

Conclusions:

  • Effective risk stratification in NSTEACS is essential for guiding timely and appropriate treatment.
  • Current guidelines advocate for an early invasive approach in higher-risk NSTEACS populations.
  • Integrating multiple markers into risk scores improves prognostic accuracy and treatment selection.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...